|
|
FDADocs 5/9/2008 | 0 (0) | 45 | 0 | 0 | English
Session IIIDrug ShortagesIndustry Perspective FDA/CDER Drug Shortage website Oncology Times... oncology SuggestionsImportant Drug List(COG IAC Meeting 2003)Year of Approval Actinomycin d E ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 41 | 0 | 0 | English
Compliance Policy Guide Guidance for FDA Staff Sec. 555.320 Listeria monocytogenes DRAFT GUIDANCE'This guidance document is being distributed for comment purposes only. ('omments and ... more>>
FDADocs 5/5/2008 | 0 (0) | 38 | 4 | 0 | English
Cell Therapy and FDA RegulationCelia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies Mid-Atlantic Bio October 25, 2007 Bethesda, MarylandOutline ... more>>
FDADocs 5/9/2008 | 0 (0) | 24 | 0 | 0 | English
ERRATA TO FDA BRIEFING DOCUMENT1.The following items in the briefing document need to be corrected. Deletions are indicated by strikethrough and corrections are in italics.??? ???Page ... more>>
FDADocs 5/8/2008 | 0 (0) | 11 | 1 | 0 | English
Cancer Nanotechnology: New Opportunities for Targeted TherapiesFDA Public Meeting October 10, 2006Piotr Grodzinski, Ph.D. Director, Nanotechnology for Cancer Programs Office of Technology and ... more>>
FDADocs 5/9/2008 | 0 (0) | 77 | 1 | 0 | English
Judy Staffa, co-leads, presiding. PRESENT: SOLOMON IYASU JUDY STAFFA LANA PAULS GERALD DAL PAN FDA FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 63 | 0 | 0 | English
DISTRICT ADDRESS AND PHONE NO.DEPARTMENT OF HEALTH AND HUMAN SERVICESFOOD AND DRUG ADMINISTRATIONNAME AND TITLE OF INDIVIDUAL300 S. Riverside Plaza, Suite 550 South Chi... ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 45 | 1 | 0 | English
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLPDocument issued on: June 2004U.S. Department of Health and Human Services Food and Drug ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 48 | 0 | 0 | English
Draft Guidance for Industry and FDA Staff Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza VirusesDRAFT ... more>>
FDADocs 5/5/2008 | 0 (0) | 23 | 0 | 0 | English
Draft ??? Not for ImplementationAttachment III Sample Formats ??? Form FDA 356h for Ammonia N 13 Injection Fleudioxyglucose F 18 Injection (FDG F 18) and Sodium Fluoride F 18 InjectionJ:\!PET ... more>>
FDADocs 5/9/2008 | 0 (0) | 31 | 0 | 0 | English
/FDA/ORA/HQ/OE/DEIO Building PKLN Room RM1490 (Mail stop HFC-1) Rockville MD 20857 Dear Sir: We are aware that the FDA has undertaken a 60-day review of various forms of labels, tags and tamper evident ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 31 | 0 | 0 | English
Health and Human ServicesMEDWATCHThe FDA Safety Information and Adverse Event Reporting Program A... problems and product use errorsGeneral Instructions3. Sex Female Male orFDA USE ONLYTriage ... more>>
FDADocs 5/9/2008 | 0 (0) | 41 | 0 | 0 | English
THE CENTER FOR LIFESTYLE DISEASE~b-6 ~7~P.O . Box 1487" Surprise, AZ 85378July 18, 2006FDA Pre Market Notification for "Absolbotani"Submitted By: This Pre Market Notification is being ... more>>
FDADocs 5/9/2008 | 0 (0) | 33 | 0 | 0 | English
Session II:Exjade?? Phase 4 requirementsExjade ?? (deferasirox) Tablets for Oral Suspension (accelerated approval Nov. 2, 2005)DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health Service ... more>>
FDADocs 5/9/2008 | 0 (0) | 36 | 0 | 0 | English
Session II:Exjade?? Phase 4 requirementsExjade ?? (deferasirox) Tablets for Oral Suspension (accelerated approval Nov. 2, 2005)DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health Service ... more>>
| | | |
| results / page 15/25/50 |
Page: 7 of 33
|
...7...
|
|